|
Market Closed -
Euronext Paris
18:55:00 19/08/2026 +03
|
5-day change | 1st Jan Change | ||
| 4.410 EUR | +3.76% |
|
+0.68% | +106.07% |
| 07-09 | THX Pharma secures its financial roadmap |  |
| 06-23 | THX Pharma appoints Sophie Jacq Lapointe to its board of directors | |
| Market Cap | 60.84M 70.93M 56.81M 52.12M 98.02M 6.78B 99.63M 670M 263M 3.4B 266M 261M 11.24B | P/E 2026 * |
-
| P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 37.14M 43.3M 34.68M 31.82M 59.84M 4.14B 60.82M 409M 160M 2.08B 163M 159M 6.86B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | - |
| Free-Float |
91.97% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | +3.76% | ||
| 1 week | +0.68% | ||
| Current month | +2.56% | ||
| 1 month | +19.35% | ||
| 3 months | +33.64% | ||
| 6 months | +28.20% | ||
| Current year | +106.07% |
| 1 week | 3.96 |  | 4.5 |
| 1 month | 3.67 | | 4.75 |
| Current year | 1.83 | | 5.1 |
| 1 year | 1.49 | | 5.1 |
| 3 years | 0.26 | | 5.1 |
| 5 years | 0.26 | | 9.27 |
| 10 years | 0.26 | | 23.6 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 01/01/2023 | |
Christine Placet
DFI | Director of Finance/CFO | - | 01/04/2024 |
Marie Sebille
CTO | Chief Tech/Sci/R&D Officer | - | 19/10/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | - | 31/03/2024 | |
| Chairman | - | 31/03/2024 | |
Julien Veys
BRD | Director/Board Member | - | - |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 4/3/26 A | Buy | Chief Operating Officer | 4,944 | 0.0342% | ||
| 1/28/21 A | Sell | Chief Financial Officer | 750 | 0.0207% | ||
| 1/28/21 A | Sell | Chief Financial Officer | 1,000 | 0.0276% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +3.76% | +0.68% | +86.08% | +283.48% | 70.93M | |
| -1.90% | +3.12% | +81.70% | +110.88% | 72.21B | |
| +0.87% | +15.32% | +56.99% | +95.59% | 63.98B | |
| +1.71% | -1.22% | +2.71% | +501.29% | 28.53B | |
| +4.91% | +9.80% | +63.95% | +26.13% | 25.07B | |
| +21.96% | +21.98% | +1.54% | +2.50% | 28.42B | |
| +2.28% | +5.65% | +42.00% | -12.34% | 20.04B | |
| 0.00% | -2.78% | +247.46% | +423.83% | 18.19B | |
| +3.25% | +3.14% | +25.75% | +537.65% | 15.96B | |
| +2.39% | +7.96% | +44.96% | +157.77% | 13.48B | |
| Average | +3.94% | +5.22% | +65.31% | +212.68% | 28.6B | |
| Weighted average by Cap. | +2.96% | +6.69% | +61.68% | +165.56% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | - |
| Net income | 11.9M 13.87M 11.11M 10.19M 19.17M 1.33B 19.49M 131M 51.34M 665M 52.09M 50.96M 2.2B | 4.3M 5.01M 4.02M 3.68M 6.93M 479M 7.04M 47.38M 18.55M 240M 18.82M 18.41M 795M |
| Net Debt | -23.7M -27.63M -22.13M -20.3M -38.18M -2.64B -38.81M -261M -102M -1.32B -104M -101M -4.38B | -27.4M -31.94M -25.59M -23.47M -44.14M -3.05B -44.87M -302M -118M -1.53B -120M -117M -5.06B |
Employees
12
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 19/08/26 | €4.410 | +3.76% | 96,802 |
| 18/08/26 | €4.250 | +4.94% | 179,155 |
| 17/08/26 | €4.050 | -0.74% | 89,848 |
| 14/08/26 | €4.080 | -3.89% | 230,643 |
| 13/08/26 | €4.245 | -3.08% | 83,213 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
4.410EUR
Average target price
5.800EUR
Spread / Average Target
+31.52%
Annual profits - Rate of surprise
- Stock Market
- Stocks
- ALTHX Stock
Select your edition
All financial news and data tailored to specific country editions
